Skip to main content
Erschienen in: The Journal of Obstetrics and Gynecology of India 6/2014

01.12.2014 | Invited Mini Review

Diagnosis and Management of Formerly Called “Dysfunctional Uterine Bleeding” According to PALM-COEIN FIGO Classification and the New Guidelines

verfasst von: Mohamed Khrouf, Khaled Terras

Erschienen in: The Journal of Obstetrics and Gynecology of India | Ausgabe 6/2014

Einloggen, um Zugang zu erhalten

Abstract

In 2011, the FIGO classification system (PALM-COEIN) was published to standardize terminology, diagnostic and investigations of causes of abnormal uterine bleeding (AUB). According to FIGO new classification, in the absence of structural etiology, the formerly called “dysfunctional uterine bleeding” should be avoided and clinicians should state if AUB are caused by coagulation disorders (AUB-C), ovulation disorder (AUB-O), or endometrial primary dysfunction (AUB-E). Since this publication, some societies have released or revised their guidelines for the diagnosis and the management of the formerly called “dysfunctional uterine bleeding” according new FIGO classification. In this review, we summarize the most relevant new guidelines for the diagnosis and the management of AUB-C, AUB-O, and AUB-E.
Literatur
1.
Zurück zum Zitat Munro MG, Critchley HO, Broder MS, et al. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet. 2011;113(1):3–13.PubMedCrossRef Munro MG, Critchley HO, Broder MS, et al. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet. 2011;113(1):3–13.PubMedCrossRef
2.
Zurück zum Zitat Diagnosis of abnormal uterine bleeding in reproductive aged women. Practice Bulletin No. 128. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2012; 120(1):197–206. Diagnosis of abnormal uterine bleeding in reproductive aged women. Practice Bulletin No. 128. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2012; 120(1):197–206.
3.
Zurück zum Zitat Management of abnormal uterine bleeding associated with ovulatory dysfunction. Practice Bulletin No. 136. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2013;122(1):176–85. Management of abnormal uterine bleeding associated with ovulatory dysfunction. Practice Bulletin No. 136. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2013;122(1):176–85.
4.
Zurück zum Zitat Singh S, Best C, Dunn S, et al. Abnormal uterine bleeding in pre-menopausal women. J Obstet Gynaecol Can. 2013;35(5):473–9.PubMed Singh S, Best C, Dunn S, et al. Abnormal uterine bleeding in pre-menopausal women. J Obstet Gynaecol Can. 2013;35(5):473–9.PubMed
5.
Zurück zum Zitat Matteson KA, Rahn DD, Wheeler TL 2nd, et al. Nonsurgical management of heavy menstrual bleeding: a systematic review. Obstet Gynecol. 2013;121(3):632–43.PubMedCrossRef Matteson KA, Rahn DD, Wheeler TL 2nd, et al. Nonsurgical management of heavy menstrual bleeding: a systematic review. Obstet Gynecol. 2013;121(3):632–43.PubMedCrossRef
6.
Zurück zum Zitat Fadhlaoui A, Khrouf M, Chelbi A, et al. Quality of life during menstruation in women with an inherited bleeding disorder: report of 31 cases. Tunis Med. 2012;90(12):856–61.PubMed Fadhlaoui A, Khrouf M, Chelbi A, et al. Quality of life during menstruation in women with an inherited bleeding disorder: report of 31 cases. Tunis Med. 2012;90(12):856–61.PubMed
7.
Zurück zum Zitat Shankar M, Lee CA, Sabin CA, et al. von Willebrand disease in women with menorrhagia: a systematic review. BJOG. 2004;111(7):734–40.PubMedCrossRef Shankar M, Lee CA, Sabin CA, et al. von Willebrand disease in women with menorrhagia: a systematic review. BJOG. 2004;111(7):734–40.PubMedCrossRef
8.
Zurück zum Zitat Kouides PA, Conard J, Peyvandi F, et al. Hemostasis and menstruation: appropriate investigation for underlying disorders of hemostasis in women with excessive menstrual bleeding. Fertil Steril. 2005;84(5):1345–51.PubMedCrossRef Kouides PA, Conard J, Peyvandi F, et al. Hemostasis and menstruation: appropriate investigation for underlying disorders of hemostasis in women with excessive menstrual bleeding. Fertil Steril. 2005;84(5):1345–51.PubMedCrossRef
9.
Zurück zum Zitat Gleeson NC. Cyclic changes in endometrial tissue plasminogen activator and plasminogen activator inhibitor type 1 in women with normal menstruation and essential menorrhagia. Am J Obstet Gynecol. 1994;171(1):178–83.PubMedCrossRef Gleeson NC. Cyclic changes in endometrial tissue plasminogen activator and plasminogen activator inhibitor type 1 in women with normal menstruation and essential menorrhagia. Am J Obstet Gynecol. 1994;171(1):178–83.PubMedCrossRef
10.
Zurück zum Zitat Smith SK, Abel MH, Kelly RW, et al. A role for prostacyclin (PGi2) in excessive menstrual bleeding. Lancet. 1981;1(8219):522–4.PubMedCrossRef Smith SK, Abel MH, Kelly RW, et al. A role for prostacyclin (PGi2) in excessive menstrual bleeding. Lancet. 1981;1(8219):522–4.PubMedCrossRef
11.
Zurück zum Zitat Hickey M, Higham JM, Fraser I, et al. Progestogens with or without oestrogen for irregular uterine bleeding associated with anovulation. Cochrane Database Syst Rev. 2012;9:CD001895.PubMed Hickey M, Higham JM, Fraser I, et al. Progestogens with or without oestrogen for irregular uterine bleeding associated with anovulation. Cochrane Database Syst Rev. 2012;9:CD001895.PubMed
Metadaten
Titel
Diagnosis and Management of Formerly Called “Dysfunctional Uterine Bleeding” According to PALM-COEIN FIGO Classification and the New Guidelines
verfasst von
Mohamed Khrouf
Khaled Terras
Publikationsdatum
01.12.2014
Verlag
Springer India
Erschienen in
The Journal of Obstetrics and Gynecology of India / Ausgabe 6/2014
Print ISSN: 0971-9202
Elektronische ISSN: 0975-6434
DOI
https://doi.org/10.1007/s13224-014-0641-1

Weitere Artikel der Ausgabe 6/2014

The Journal of Obstetrics and Gynecology of India 6/2014 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.